Transcatheter aortic valve implantation in acute decompensated aortic stenosis
Authors:
- 6 November 2019
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 96 (3) , E348-E354
Abstract
Objectives: To assess the safety and efficacy of first‐line transcatheter aortic valve implantation (TAVI) in patients presenting with acute decompensated aortic stenosis (ADAS).Background: ADAS is common and is often treated medically or using balloon aortic valvuloplasty in the first instance. This temporizing measure results in suboptimal outcomes. In the current era, TAVI provides an alternative option.Methods: Consecutive patients who had either a TAVI for ADAS or electively were included in the study. The primary outcome was procedural and 30‐day mortality and hospital length of stay (LOS). Secondary outcomes included 1‐year mortality and procedural complications.Results: Of note, 893 patients (mean age 83 ± 7, 50.5% male) underwent TAVI (19% ADAS, 81% elective). ADAS patients were more unwell with worse echocardiographic parameters than elective patients. ADAS patients of 55.9% were known to have significant aortic stenosis prior to their decompensation. Procedural mortality was not different between the ADAS and elective cohorts (1.2 vs. 0.7%; p = .62). The ADAS cohort had a higher 30‐day mortality (5.3 vs. 1.1%; p = .002) and longer LOS (31.9 ± 20.7 days vs. 6.1 ± 6.5 days; p < .001). Multivariate analysis identified acute kidney injury and ADAS as significant predictors of 30‐day mortality.Conclusions: TAVI for ADAS is safe and effective with procedural outcomes similar to elective patients. However, compared to elective patients, they have worse physiological baseline features, poorer prognosis at 30 days, and longer hospital admissions. Majority of patients who presented with ADAS were known to have AS prior to admission.Keywords
Funding Information
- Edwards Lifesciences
This publication has 16 references indexed in Scilit:
- Successful Treatment of Congestive Heart Failure Due to Severe Aortic Valve Stenosis With Low Dose Tolvaptan in Elderly PatientsInternational Heart Journal, 2017
- Urgent Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis and Acute Heart Failure: Procedural and 30-Day OutcomesCanadian Journal of Cardiology, 2016
- Emergency transcatheter aortic valve replacement in patients with cardiogenic shock due to acutely decompensated aortic stenosisEuroIntervention, 2016
- 5-Year Outcomes After Transcatheter Aortic Valve Implantation With CoreValve ProsthesisJACC: Cardiovascular Interventions, 2015
- Outcomes of surgical aortic valve replacement for severe aortic stenosis: Incorporation of left ventricular systolic function and stroke volume indexThe Journal of Thoracic and Cardiovascular Surgery, 2015
- 147 THE INDICATIONS AND OUTCOMES OF BALLOON AORTIC VALVULOPLASTY: A SINGLE CENTRE EXPERIENCEHeart, 2013
- Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document†European Heart Journal, 2012
- Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo SurgeryNew England Journal of Medicine, 2010
- Burden of valvular heart diseases: a population-based studyThe Lancet, 2006
- Balloon aortic valvuloplasty as a bridge to aortic valve replacement in critically ill patientsThe Annals of Thoracic Surgery, 1993